Managers

Bitcoin Venture Alpha East panelist Avedisian – video

Margaux Avedisian talks to VCJ about using the cryptocurrency to travel the world

Hogging the credit: Why software is eating banking

Banking brands Wells Fargo, BofA and Chase are on top of the heap now. Will they soon be replaced by the emerging financial startups and innovators?

Accel Partners closes two funds adding up to nearly $1.5 bln

Accel Partners, the Palo Alto, Calif.-based venture firm that was an early investor in Facebook, has closed two news funds totaling $1.475 billion. The firm raised $475 million for its 12th main fund, the same size as Accel XI, which closed in 2011. The firm also raised $1 billion for Accel Growth III, exceeding the $875 million that the firm raised for its second growth fund, which also dates back to 2011, according to Thomson Reuters.

Accel Partners closes two funds adding up to nearly $1.5 bln

Accel Partners, the Palo Alto, Calif.-based venture firm that was an early investor in Facebook, has closed two news funds totaling $1.475 billion. The firm raised $475 million for its 12th main fund, the same size as Accel XI, which closed in 2011. The firm also raised $1 billion for Accel Growth III, exceeding the $875 million that the firm raised for its second growth fund, which also dates back to 2011, according to Thomson Reuters.

Data spotlight: Top security investors include unexpected names

Security investing dips slightly in 2013 but activity remains high

In memoriam: Tom Judge remembered as plain speaker, wise counselor

Former PE chief at AT&T, investor was a pioneering LP

Apax to create $500 mln Israel mid-market fund-Reuters

British private equity fund Apax Partners said on Wednesday it will create a $500 million mid-market fund to invest in Israeli companies in the technology, telecom, healthcare and consumer sectors, Reuters reported.

Apax to create $500 mln Israel mid-market fund-Reuters

British private equity fund Apax Partners said on Wednesday it will create a $500 million mid-market fund to invest in Israeli companies in the technology, telecom, healthcare and consumer sectors, Reuters reported.

Ysios Capital targets $78.7 mln for Fund II

Ysios Capital said Wednesday it has begun seeking investors for its Ysios BioFund II, a 100 million Euro fund (US $78.7 million). Fund II will invest in life sciences companies with disruptive products, platforms or technologies in the pharmaceutical and medtech and diagnostics segments. Ysios BioFund I closed at 69 million Euro in 2008.

CalPERS sets $200 mln more for emerging managers

No word on buyouts, VC allocations for new FoF vehicle